Andrew J Gawron1, Reginald Bell2, Barham K Abu Dayyeh3, F P Buckley4, Kenneth Chang5, Christy M Dunst6, Steven A Edmundowicz7, Blair Jobe8, John C Lipham9, Dan Lister10, Marcia Irene Canto11, Michael S Smith12, Anthony A Starpoli13, George Triadafilopoulos14, Thomas J Watson15, Erik Wilson16, John E Pandolfino17, Alexander Kaizer7, Zoe Van De Voorde7, Rena Yadlapati18. 1. University of Utah and Salt Lake City VA Medical Center, Salt Lake City, Utah, USA. 2. Institute of Esophageal and Reflux Surgery, Denver, Colorado, USA. 3. Mayo Clinic, Rochester, Minnesota, USA. 4. University of Texas- Dell Medical School, Austin, Texas, USA. 5. University of California Irvine, Irvine, California, USA. 6. The Oregon Clinic, Portland, Oregon, USA. 7. University of Colorado, Aurora, Colorado, USA. 8. Allegheny Health Network, Greensburg, Pennsylvania, USA. 9. University of Southern California, Los Angeles, California, USA. 10. Arkansas Heartburn Treatment Center, Heber Springs, Arkansas, USA. 11. Johns Hopkins University, Baltimore, Maryland, USA. 12. Mount Sinai West & Mount Sinai Morningside Hospitals, New York, New York, USA. 13. NYU Langone Medical Center & Northwell Lenox Hill Hospital, New York, New York, USA. 14. Stanford University, Stanford, California, USA. 15. MedStar Georgetown University Hospital, Washington, DC, USA. 16. University of Texas McGovern Medical School, Houston, Texas, USA. 17. Northwestern University, Chicago, Illinois, USA. 18. University of Colorado, Aurora, Colorado, USA; University of California San Diego, San Diego, California, USA.
Abstract
BACKGROUND AND AIMS: The objective of this study was to examine expert opinion and agreement on the treatment of distinct GERD profiles from surgical and therapeutic endoscopy perspectives. METHODS: We used the RAND/University of California, Los Angeles Appropriateness Method over 6 months (July 2018 to January 2019) to assess the appropriateness of antireflux interventions among foregut surgeons and therapeutic gastroenterologists. Patients with primary atypical or extraesophageal symptoms were not considered. Patient scenarios were grouped according to their symptom response to proton pump inhibitor (PPI) therapy. The primary outcome was appropriateness of an intervention. RESULTS: Antireflux surgery with laparoscopic fundoplication (LF) and magnetic sphincter augmentation (MSA) were ranked as appropriate for all complete and partial PPI responder scenarios. Transoral incisionless fundoplication was ranked as appropriate in complete and partial PPI responders without a hiatal hernia. Radiofrequency energy was not ranked as appropriate for complete or partial responders. There was lack of agreement between surgery and interventional gastroenterology groups on the appropriateness of LF and MSA for PPI nonresponders. Rankings for PPI nonresponders were similar when results from impedance-pH testing on PPI therapy were available, except that LF and MSA were not ranked as appropriate for PPI nonresponders if the impedance-pH study was negative. CONCLUSIONS: This work highlights areas of agreement for invasive therapeutic approaches for GERD and provides impetus for further interdisciplinary collaboration and trials to compare and generate novel and effective treatment approaches and care pathways, including the role of impedance-pH testing in PPI nonresponders.
BACKGROUND AND AIMS: The objective of this study was to examine expert opinion and agreement on the treatment of distinct GERD profiles from surgical and therapeutic endoscopy perspectives. METHODS: We used the RAND/University of California, Los Angeles Appropriateness Method over 6 months (July 2018 to January 2019) to assess the appropriateness of antireflux interventions among foregut surgeons and therapeutic gastroenterologists. Patients with primary atypical or extraesophageal symptoms were not considered. Patient scenarios were grouped according to their symptom response to proton pump inhibitor (PPI) therapy. The primary outcome was appropriateness of an intervention. RESULTS: Antireflux surgery with laparoscopic fundoplication (LF) and magnetic sphincter augmentation (MSA) were ranked as appropriate for all complete and partial PPI responder scenarios. Transoral incisionless fundoplication was ranked as appropriate in complete and partial PPI responders without a hiatal hernia. Radiofrequency energy was not ranked as appropriate for complete or partial responders. There was lack of agreement between surgery and interventional gastroenterology groups on the appropriateness of LF and MSA for PPI nonresponders. Rankings for PPI nonresponders were similar when results from impedance-pH testing on PPI therapy were available, except that LF and MSA were not ranked as appropriate for PPI nonresponders if the impedance-pH study was negative. CONCLUSIONS: This work highlights areas of agreement for invasive therapeutic approaches for GERD and provides impetus for further interdisciplinary collaboration and trials to compare and generate novel and effective treatment approaches and care pathways, including the role of impedance-pH testing in PPI nonresponders.
Authors: Rena Yadlapati; Michael F Vaezi; Marcelo F Vela; Stuart J Spechler; Nicholas J Shaheen; Joel Richter; Brian E Lacy; David Katzka; Philip O Katz; Peter J Kahrilas; Prakash C Gyawali; Lauren Gerson; Ronnie Fass; Donald O Castell; Jenna Craft; Luke Hillman; John E Pandolfino Journal: Am J Gastroenterol Date: 2018-04-24 Impact factor: 10.864
Authors: Nicholas J Shaheen; Richard A Hansen; Douglas R Morgan; Lisa M Gangarosa; Yehuda Ringel; Michelle T Thiny; Mark W Russo; Robert S Sandler Journal: Am J Gastroenterol Date: 2006-07-18 Impact factor: 10.864
Authors: Reginald Bell; John Lipham; Brian Louie; Valerie Williams; James Luketich; Michael Hill; William Richards; Christy Dunst; Dan Lister; Lauren McDowell-Jacobs; Patrick Reardon; Karen Woods; Jon Gould; F Paul Buckley; Shanu Kothari; Leena Khaitan; C Daniel Smith; Adrian Park; Christopher Smith; Garth Jacobsen; Ghulam Abbas; Philip Katz Journal: Gastrointest Endosc Date: 2018-07-18 Impact factor: 9.427
Authors: Jan G Hatlebakk; Frank Zerbib; Stanislas Bruley des Varannes; Stephen E Attwood; Christian Ell; Roberto Fiocca; Jean-Paul Galmiche; Stefan Eklund; Göran Långström; Tore Lind; Lars R Lundell Journal: Clin Gastroenterol Hepatol Date: 2015-07-27 Impact factor: 11.382
Authors: C Prakash Gyawali; Peter J Kahrilas; Edoardo Savarino; Frank Zerbib; Francois Mion; André J P M Smout; Michael Vaezi; Daniel Sifrim; Mark R Fox; Marcelo F Vela; Radu Tutuian; Jan Tack; Albert J Bredenoord; John Pandolfino; Sabine Roman Journal: Gut Date: 2018-02-03 Impact factor: 23.059
Authors: S Roman; C P Gyawali; E Savarino; R Yadlapati; F Zerbib; J Wu; M Vela; R Tutuian; R Tatum; D Sifrim; J Keller; M Fox; J E Pandolfino; A J Bredenoord Journal: Neurogastroenterol Motil Date: 2017-03-31 Impact factor: 3.598
Authors: Thomas R McCarty; Pichamol Jirapinyo; Lyndon P James; Sanchit Gupta; Walter W Chan; Christopher C Thompson Journal: Endosc Int Open Date: 2022-07-15
Authors: Rena Yadlapati; Melina Masihi; C Prakash Gyawali; Dustin A Carlson; Peter J Kahrilas; Billy Darren Nix; Anand Jain; Joseph R Triggs; Michael F Vaezi; Leila Kia; Alexander Kaizer; John E Pandolfino Journal: Gastroenterology Date: 2020-09-16 Impact factor: 22.682